INS and type 2 diabetes mellitus: In fact, pioglitazone reduced hepatic TAG content, glucose and insulin levels in plasma, improving hepatic, muscle and adipose tissue insulin-sensitivity in patients with prediabetes or T2DM and biopsy-proven NASH [175].